arrow
F

Floris H. P. van Velden

leiden university medical center
H指数:31
被引数:7,129

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diagnostic accuracy and clinical value of quantitative Na[18F]F PET/CT parameters to monitor therapeutic response in patients with benign metabolic bone diseases: A systematic review

定量<sup>18</sup>F-FNa PET/CT参数在监测良性代谢性骨病患者治疗反应中的诊断准确性和临床价值:一项系统综述

2026-10-280
OAAI
A phantom study to achieve comparable 124I PET recovery and address scanner variability for dosimetry purposes in (re)differentiated thyroid cancer

一种实现比较性¹²⁴I PET回收率并解决分化型甲状腺癌剂量测定中扫描仪变异性的体模研究

2026-05-010
OAAI
[89Zr]bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic NF2-related schwannomatosis: a study protocol for a phase II single centre, prospective, feasibility trial

[89Zr]贝伐珠单抗PET/CT成像在预测症状性NF2相关神经鞘瘤病患者贝伐珠单抗治疗效果中的应用:一项针对单中心、前瞻性、可行性II期试验的研究方案

2026-04-080
OA
No reinduction of clinically relevant radioiodine uptake after lenvatinib treatment in radioidine-refractory differentiated thyroid cancer

在接受放射性碘难治性分化型甲状腺癌患者中,lenvatinib治疗后未观察到临床相关的再次诱导放射性碘摄取。

2025-12-160
OAAI
Multicollinearity and redundancy of the PET radiomic feature set

PET影像组学特征集的多重共线性与冗余性

2025-05-070
OA
Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [18F]FDG in gynaecological malignancies: systematic literature review and meta-analysis

头对头比较成纤维细胞活化蛋白抑制剂(FAPI)放射性药物与[18F]FDG在妇科恶性肿瘤中的研究:系统文献综述和荟萃分析

2025-04-250
OA
PSMA expression and PSMA PET/CT imaging in metastatic soft tissue sarcoma patients, results of a prospective study

PSMA表达及PSMA PET/CT成像在转移性软组织肉瘤患者中的应用,前瞻性研究结果

2025-03-270
OA
Measuring Total Metabolic Tumor Volume from 18F-FDG PET: A Reality Check

通过18F-FDG PET测量总代谢肿瘤体积:一次现实核查

2025-03-130
PRE
Integrating Clinical Variables, Radiomics, and Tumor-derived Cell-Free DNA for Enhanced Prediction of Resectable Esophageal Adenocarcinoma Outcomes

整合临床变量,放射组学和肿瘤衍生的细胞游离DNA,以增强可切除食管腺癌预后的预测

2025-03-010
OAAI
Preoperative [18F]fluoro-PEG-folate PET/CT in advanced stage epithelial ovarian cancer: A safety and feasibility study
2024-11-010
OAAI
Challenges in Pharmacokinetic Modelling of [18F]fluoro-PEG-folate PET/CT Imaging in Epithelial Ovarian Cancer Patients
2024-05-221
OAAI
Is PET Radiomics Useful to Predict Pathologic Tumor Response and Prognosis in Locally Advanced Cervical Cancer?

PET放射组学对预测局部晚期宫颈癌的病理肿瘤反应和预后有用吗?

2024-03-281
OA